Semaglutide use is associated with neuromuscular junction degradation in older adults with type II diabetes mellitus.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Semaglutide use is associated with neuromuscular junction degradation in older adults with type II diabetes mellitus.
- Published In:
- British journal of clinical pharmacology, 92(1), 149-161 (2026)
- Authors:
- Qaisar, Rizwan, Khan, Imran Ullah, Rehman, Atif Ur, Iqbal, M Shahid, Ahmad, Firdos, Karim, Asima
- Database ID:
- RPEP-15935
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-15935APA
Qaisar, Rizwan; Khan, Imran Ullah; Rehman, Atif Ur; Iqbal, M Shahid; Ahmad, Firdos; Karim, Asima. (2026). Semaglutide use is associated with neuromuscular junction degradation in older adults with type II diabetes mellitus.. British journal of clinical pharmacology, 92(1), 149-161. https://doi.org/10.1002/bcp.70253
MLA
Qaisar, Rizwan, et al. "Semaglutide use is associated with neuromuscular junction degradation in older adults with type II diabetes mellitus.." British journal of clinical pharmacology, 2026. https://doi.org/10.1002/bcp.70253
RethinkPeptides
RethinkPeptides Research Database. "Semaglutide use is associated with neuromuscular junction de..." RPEP-15935. Retrieved from https://rethinkpeptides.com/research/qaisar-2026-semaglutide-use-is-associated
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.